MedPath

TRIZIVIR

TRIZIVIR

Discontinued
DIN Number

02244757

Drug Class

Human

Market Date

Oct 29, 2001

Company
HC

viiv healthcare ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02244757
AIG Number0345541001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR04 ZIDOVUDINE, LAMIVUDINE AND ABACAVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification

ACTIVE INGREDIENTS (3)

ABACAVIR (ABACAVIR SULFATE)Active
Strength: 300 MG
Monograph: ABACAVIR (ABACAVIR SULFATE)
LAMIVUDINEActive
Strength: 150 MG
Monograph: LAMIVUDINE
ZIDOVUDINEActive
Strength: 300 MG
Monograph: ZIDOVUDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.